26345 Aspergillus fumigatus, IgG Antibodies, Serum(SASP)

​Aspergillus fumigatus, IgG Antibodies, Serum (SASP), A fumigatus, IgG Antibodies 

​Evaluation of patients suspected of having lung disease caused by Aspergillus fumigatus

Gross Hemolysis

Gross Lipemia

​IgG antibodies to Aspergillus fumigatus, Thermoactinomyces vulgaris, or Micropolyspora faeni may be found in sera from healthy individuals; the presence of these specific antibodies is not sufficient to establish the diagnosis of hypersensitivity pneumonitis (HP).

Elevated concentration of antibodies to Aspergillus fumigatus may be also found in patients with invasive aspergillosis and cavitary lung disease.

The concentrations of antibodies to these antigens may decrease following treatment, although elevated concentrations may persist in treated patients.

​Aspergillus fumigatus is one of the causative agents of hypersensitivity pneumonitis (HP), as well as invasive lung disease with cavitation or pneumonitis and allergic bronchopulmonary disease. Other causative microorganisms of HP include Micropolyspora faeni and Thermoactinomyces vulgaris. The development of HP and allergic bronchopulmonary disease caused by Aspergillus fumigatus is accompanied by an immune response to Aspergillus fumigatus antigens with production of IgG or IgE antibodies, respectively. While the immunopathogenesis of HP and allergic bronchopulmonary disease is not known, several immune mechanisms are postulated to play a role, including both cellular and humoral mechanisms.

​Elevated concentrations of IgG antibodies to Aspergillus fumigatus, Thermoactinomyces vulgaris, or Micropolyspora faeni in patients with signs and symptoms of hypersensitivity pneumonitis may be consistent with disease caused by exposure to 1 or more of these organic antigens.